Cravatex

Who are the top shareholders of the Cravatex?

The top shareholder of Cravatex is R B Fitness And Trading Private Limited, holding 74.36% of the shares. Individual investors own 21.13%, while the highest public shareholder is Mahesh Parameswaran Nair with 2.01%.

The top shareholders of Cravatex are primarily the promoters, with R B Fitness And Trading Private Limited holding the largest stake at 74.36%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is Mahesh Parameswaran Nair, who owns 2.01%. Additionally, individual investors collectively hold 21.13% of the shares.

Who are in the management team of Cravatex?

As of March 2023, the management team of Cravatex includes Rajesh Batra (Chairman & Managing Director), S D Israni, N Santhanam, and Pheroza Jimmy Bilimoria (Independent Directors), Sudhanshu Namdeo (Company Secretary & Compliance Officer), Divakar Ganapati Kamath (Executive Director & CFO), and Rohan Batra (Director). Each member contributes to the company's governance and operations.

As of March 2023, the management team of Cravatex includes the following individuals:<BR><BR>1. Rajesh Batra - Chairman & Managing Director<BR>2. S D Israni - Independent Director<BR>3. Sudhanshu Namdeo - Company Secretary & Compliance Officer<BR>4. N Santhanam - Independent Director<BR>5. Pheroza Jimmy Bilimoria - Independent Director<BR>6. Divakar Ganapati Kamath - Executive Director & CFO<BR>7. Rohan Batra - Director<BR><BR>Each member plays a significant role in the governance and operational management of the company.

What does Cravatex do?

Cravatex Ltd is a micro-cap company in the Trading & Distributors industry, specializing in sports goods and fitness equipment, with recent net sales of 61 Cr and a net profit of 1 Cr as of March 2025. It has a market cap of Rs 111 Cr and key metrics include a P/E of 23.00 and a dividend yield of 0.70%.

Overview: <BR>Cravatex Ltd is a micro-cap company operating in the Trading & Distributors industry, specializing in sports goods and fitness equipment.<BR><BR>History: <BR>Cravatex Ltd was incorporated in 1951 by Ram Kumar Batra and is part of The Batra Group. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 61 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 111 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 23.00 <BR>Industry P/E: 30 <BR>Dividend Yield: 0.70% <BR>Debt Equity: -0.86 <BR>Return on Equity: 4.53% <BR>Price to Book: 1.04<BR><BR>Contact Details: <BR>Address: Unit-201 2nd Flr Matulya Centr, S B Marg Lower Parel Mumbai Maharashtra : 400013 <BR>Email: investors@cravatex.com <BR>Website: http://www.cravatex.com

What is the bonus history of the Cravatex?

Cravatex Ltd had a bonus issue of 1:1 announced on July 15, 2011, with a record date of July 19, 2011, allowing shareholders to receive one additional share for each share held.

Cravatex Ltd has a bonus history that includes a 1:1 bonus issue announced on July 15, 2011. The record date for this bonus was July 19, 2011. This means that shareholders received one additional share for every share they held as of the record date.

Has Cravatex declared dividend?

Cravatex Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of July 30, 2024. The company has shown strong long-term growth, achieving a total return of 62.43% over the past five years.

Cravatex Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: Jul-30-2024<BR><BR>Dividend Yield: 0.7%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, Cravatex experienced a price return of -2.99% with no dividend return, resulting in a total return of -2.99%.<BR><BR>Over the past year, the company had a price return of 6.39% and a dividend return of 0.75%, leading to a total return of 7.14%.<BR><BR>In the 2-year period, Cravatex achieved a price return of 44.52% and a dividend return of 1.08%, culminating in a total return of 45.6%.<BR><BR>For the 3-year period, the price return was 15.36% with a dividend return of 2.34%, resulting in a total return of 17.7%.<BR><BR>In the last 4 years, Cravatex saw a price return of 47.98% and a dividend return of 3.48%, giving a total return of 51.46%.<BR><BR>Over the 5-year period, the company recorded a price return of 58.5% along with a dividend return of 3.93%, resulting in a total return of 62.43%.<BR><BR>Overall, Cravatex has declared a significant dividend, and while the recent total returns show variability, the long-term performance indicates strong growth, particularly over the 5-year period.

Who are the peers of the Cravatex?

Cravatex's peers include Redington, MMTC, MSTC, Ravindra Energy, Dhanlaxmi Cotex, Excel Realty, Safa Systems, and Chandrima Mercan. In terms of management risk, growth, and capital structure, Redington stands out positively, while Cravatex shows below-average capital structure and moderate returns.

Peers: The peers of Cravatex are Redington, MMTC, MSTC, Ravindra Energy, Dhanlaxmi Cotex, Excel Realty, Safa Systems, and Chandrima Mercan.<BR><BR>Quality Snapshot: Excellent management risk is observed at Redington, while Average management risk is found at MMTC, MSTC, and Cravatex. Below Average management risk is noted for Ravindra Energy, Dhanlaxmi Cotex, Excel Realty, Safa Systems, and Chandrima Mercan. In terms of Growth, Excellent growth is seen at Redington, Good growth at Chandrima Mercan, Average growth at Dhanlaxmi Cotex, and the rest exhibit Below Average growth. For Capital Structure, Excellent capital structure is present at MSTC and Dhanlaxmi Cotex, Good at Redington, and Below Average at Cravatex, Ravindra Energy, Excel Realty, Safa Systems, and Chandrima Mercan.<BR><BR>Return Snapshot: Dhanlaxmi Cotex has the highest 1-year return at 220.06%, while MSTC has the lowest at -39.89%. Cravatex's 1-year return of 6.02% is significantly lower than Dhanlaxmi Cotex's but higher than MSTC's. Additionally, the six-month returns for MSTC, Excel Realty, and Ravindra Energy are negative.

Is Cravatex overvalued or undervalued?

As of April 25, 2023, Cravatex is considered a risky investment due to its overvaluation, reflected in a PE ratio of 23.05, negative ROCE of -21.02%, and unfavorable comparisons to peers, despite a recent stock return of 11.28%.

As of 25 April 2023, Cravatex's valuation grade has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued based on its current metrics, with a PE ratio of 23.05, a Price to Book Value of 1.04, and a concerning ROCE of -21.02%. <BR><BR>When compared to peers, Cravatex's valuation stands out unfavorably; for instance, MMTC has a PE ratio of 119.39, while PTC India is valued attractively at a PE of 9.02. The negative EV to EBIT and EV to EBITDA ratios of -6.24 and -11.70, respectively, further underscore the company's financial struggles. Despite a recent stock return of 11.28% over the past month, which outperformed the Sensex's 3.86%, the overall indicators suggest that Cravatex is not a favorable investment at its current price of 439.00.

What is the technical trend for Cravatex?

As of April 28, 2025, Cravatex's technical trend is mildly bearish, influenced by mixed signals from moving averages and indicators, with weekly MACD and Bollinger Bands showing mild bullishness while monthly indicators reflect bearishness.

As of 28 April 2025, the technical trend for Cravatex has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD shows a mildly bearish trend. The Bollinger Bands on the weekly chart are mildly bullish, but the monthly view is bearish. Daily moving averages are mildly bearish, and the KST is mildly bullish on the weekly but bearish on the monthly. Dow Theory reflects a mildly bearish trend on the weekly and no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the mixed signals from the moving averages and the monthly indicators.

How big is Cravatex?

As of 24th July, Cravatex Ltd has a market capitalization of 124.00 Cr, with recent net sales of 173.77 Cr and a net profit of 4.82 Cr. The company has shareholder's funds of 106.43 Cr and total assets of 140.70 Cr.

As of 24th July, Cravatex Ltd has a market capitalization of 124.00 Cr, classified as a Micro Cap.<BR><BR>In the latest four quarters, Cravatex reported Net Sales of 173.77 Cr and a Net Profit of 4.82 Cr.<BR><BR>For the latest annual period, the company has Shareholder's Funds amounting to 106.43 Cr and Total Assets of 140.70 Cr.

When is the next results date for Cravatex?

The next results date for Cravatex is 14 November 2025.

The next results date for Cravatex is scheduled for 14 November 2025.

How has been the historical performance of Cravatex?

Cravatex has experienced significant declines in net sales and profitability, with net sales dropping from 594.33 Cr in Mar'22 to 173.76 Cr in Mar'25, and operating profit margins turning negative. Despite a reduction in total liabilities, the company has struggled to maintain revenue and profitability over recent years.

Answer:<BR>The historical performance of Cravatex shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Cravatex's net sales have seen a downward trend from 594.33 Cr in Mar'22 to 173.76 Cr in Mar'25, indicating a substantial decline in revenue. The total operating income followed a similar pattern, decreasing from 778.67 Cr in Mar'20 to 173.76 Cr in Mar'25. The company's operating profit margins have been negative in recent years, with an operating profit of -1.69 Cr in Mar'25, compared to a positive 11.30 Cr in Mar'22. Profit before tax also dropped significantly from 58.33 Cr in Mar'23 to 6.37 Cr in Mar'25, while profit after tax remained stagnant at 4.83 Cr for both Mar'25 and Mar'24, down from 58.93 Cr in Mar'23. On the balance sheet, total liabilities decreased from 441.91 Cr in Mar'20 to 140.70 Cr in Mar'25, reflecting a reduction in long-term borrowings, which were eliminated by Mar'25. Total assets also decreased from 441.91 Cr in Mar'20 to 140.70 Cr in Mar'25, with cash and cash equivalents showing a slight increase to 75.45 Cr in Mar'25 from 56.32 Cr in Mar'23. Overall, Cravatex has faced challenges in maintaining revenue and profitability, while managing its liabilities effectively.

Are Cravatex Ltd latest results good or bad?

Cravatex Ltd's latest results show a significant year-on-year profit increase of 440% and a 13.44% rise in net sales, but a troubling 28.49% sequential sales decline and an operating loss indicate serious operational challenges, leading to a "STRONG SELL" rating. Investors should be cautious due to the company's reliance on non-operating income and low Mojo score of 17 out of 100.

Cravatex Ltd's latest results indicate a challenging situation for the company. While there was a significant year-on-year increase in net profit of 440% to ₹1.35 crores and a 13.44% rise in net sales to ₹36.79 crores, these figures are somewhat misleading. The company experienced a sharp sequential decline in sales of 28.49% from the previous quarter, raising concerns about its operational stability.<BR><BR>Moreover, Cravatex reported an operating loss with a negative operating margin of 6.63%, which highlights ongoing struggles with its core business model. The dependency on non-operating income, which accounted for a substantial portion of profit before tax, raises serious questions about the sustainability of its earnings.<BR><BR>Overall, despite some positive year-on-year growth metrics, the underlying operational distress, significant volatility in sales, and the inability to generate consistent operating profits paint a concerning picture. The company has been classified with a "STRONG SELL" rating and a low Mojo score of 17 out of 100, reflecting deep-seated issues that investors should be wary of.

Should I buy, sell or hold Cravatex Ltd?

Why is Cravatex Ltd falling/rising?

As of 15-May, Cravatex Ltd's stock price is rising to Rs 358.65, up 4.95%, but it has shown mixed performance with a decline over the past month and year, indicating potential long-term challenges despite a high dividend yield.

As of 15-May, Cravatex Ltd's stock price is rising, currently at Rs 358.65, reflecting an increase of Rs 16.9 or 4.95%. This rise is notable as it outperformed the sector by 1.81% today. The stock also reached an intraday high of Rs 359.4, indicating positive trading momentum. <BR><BR>Despite this daily increase, the stock has shown mixed performance over different time frames. For instance, over the past week, it has gained 1.31%, contrasting with a decline of 2.70% in the Sensex. However, the stock has experienced a decline of 5.37% over the past month and 14.40% over the past year, suggesting a longer-term downward trend.<BR><BR>Additionally, the stock's trading activity has been characterized by erratic trading, as it did not trade on 2 out of the last 20 days. There has also been a decrease in investor participation, with delivery volume dropping by 22.77% compared to the 5-day average. Furthermore, Cravatex is currently trading below its moving averages across various periods, indicating potential weakness in the stock's performance.<BR><BR>On a positive note, the stock offers a high dividend yield of 3.66%, which may attract some investors. Overall, while the stock is experiencing a rise today, the broader context shows challenges that could affect its future performance.

Which are the latest news on Cravatex?